About Anindya Roy
Form D filings for Lila Biologics in 2023 list Anindya Roy as executive officer and director.
Anindya Roy first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Anindya Roy in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anindya Roy works with at each company, as listed on that company's latest Form D.
Lila Biologics, Inc. · Form D, Sep 28, 2023
WC
William Canestaro
Director
SG
Sheila Gujrathi
Director
JI
John Kraft, II
Chief Executive Officer and director